Implementing a same-day diagnostic pathway for suspected head and neck cancer in a resource-limited clinic
You are the clinical lead of a community otolaryngology clinic serving a rural region. Patients with suspected head and neck cancer currently wait a median of 21 days for a first visit and 14 more days for biopsy, with a 30% loss to follow-up. You have one flexible endoscope, two part-time ENT surgeons, and no on-site CT. You propose a same-day 'one-stop' clinic with nurse-led triage, immediate biopsy under local anesthesia where feasible, and a direct referral pathway to the regional cancer center. Administration is concerned about cost and workflow disruption.
1. How would you design and justify a same-day diagnostic pathway, and what metrics would you use to evaluate it?
Read the worked answer
Design elements:
- Nurse-led triage using a validated symptom checklist (e.g., persistent hoarseness, dysphagia, neck lump, oral ulcer >3 weeks) to identify high-risk patients for same-day slots.
- Same-day flexible endoscopy and biopsy under local anesthesia for accessible lesions; reserve operating room biopsy for inaccessible or bleeding lesions.
- Direct referral to the regional cancer center with a standardized referral form and imaging requests (CT/MRI) arranged before the visit where possible.
- Patient navigation to reduce loss to follow-up (phone reminders, transport vouchers).
Justification: reducing time to diagnosis improves stage at presentation and survival; same-day pathways are supported by evidence in head and neck cancer. Cost concerns can be addressed by reducing repeat visits and no-shows.
Metrics: time from referral to first visit, time to biopsy, time to definitive diagnosis, proportion diagnosed within 14/28 days, loss to follow-up rate, stage at diagnosis, patient satisfaction, and cost per diagnosis. Use a run chart or PDSA cycle to monitor.
2. What quality and safety safeguards are needed for same-day biopsy under local anesthesia in this setting?
Read the worked answer
Safeguards include:
- Informed consent and documented discussion of risks (bleeding, infection, inadequate sample).
- Airway and bleeding management: suction, vasoconstrictor, and a plan for uncontrolled bleeding; avoid biopsy of vascular lesions without imaging.
- Anticoagulation review and reversal if needed.
- Pathology logistics: specimen labeling, transport, and a trackable result pathway.
- Infection control: sterile technique and endoscope reprocessing per guidelines.
- Escalation plan: clear criteria for urgent transfer to the regional center.
- Audit: review complications and inadequate sample rates.
These safeguards should be written into a standard operating procedure and reviewed regularly.